FDA Inspection 1007453 — Hendrik-Tobias Arkenau
The FDA completed an inspection of Hendrik-Tobias Arkenau on Mar 23, 2017 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical Investigator (CI)